Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood  Zaraquiza Zolkipli, MSc,

Slides:



Advertisements
Similar presentations
Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
Advertisements

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
In situ imaging of honeybee (Apis mellifera) venom components from aqueous and aluminum hydroxide–adsorbed venom immunotherapy preparations Ulla Seppälä,
Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life  Carina Venter, BSc, Brett Pereira, MRCP, Jane.
A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD,
Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O
Allergen immunotherapy: A practice parameter third update
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,
Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life  Carina Venter, BSc, Brett Pereira, MRCP, Jane.
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study
Is 9 more than 2 also in allergic airway inflammation?
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,
Children with allergic and nonallergic rhinitis have a similar risk of asthma  Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy  Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
Administration of a probiotic with peanut oral immunotherapy: A randomized trial  Mimi L.K. Tang, PhD, Anne-Louise Ponsonby, PhD, Francesca Orsini, MSc,
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Diet and food allergy development during infancy: Birth cohort study findings using prospective food diary data  Kate E.C. Grimshaw, PhD, RD, Joe Maskell,
Reply Journal of Allergy and Clinical Immunology
Cats and dogs and the risk of atopy in childhood and adulthood
Jon Genuneit, MD, MSc  Journal of Allergy and Clinical Immunology 
Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S
Risk of congenital malformations for asthmatic pregnant women using a long-acting β2- agonist and inhaled corticosteroid combination versus higher-dose.
Phillip Lieberman, MD, Michael Tankersley, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
What are the best outcome measurements for atopic eczema
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
What is an “eosinophilic phenotype” of asthma?
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Diagnosis and management of early asthma in preschool-aged children
House dust mite sublingual immunotherapy: Results of a US trial
Geographic variability in childhood asthma prevalence in Chicago
High prevalence of severe asthma in a large random population study
Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L
Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis  Karl-Christian Bergmann, MD, Pascal Demoly,
A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD,
Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence  Devasmitha Venkataraman, MD, MRCPCH, MSc, Nelís Soto-Ramírez,
Prevention of food allergy: Beyond peanut
Identifying the heterogeneity of young adult rhinitis through cluster analysis in the Isle of Wight birth cohort  Ramesh J. Kurukulaaratchy, DM, FRCP,
One step forward, 2 steps back: The enigma of preschool wheeze
Risk of oral food challenges
Eosinophilic esophagitis treated with immunotherapy to dust mites
Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber 
Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens  Riikka Uotila, MD, Anna.
Jessica H. Savage, MD, MHS, Elizabeth C. Matsui, MD, MHS, Robert A
Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence  Devasmitha Venkataraman, MD, MRCPCH, MSc, Nelís Soto-Ramírez,
Atopic endotype in childhood
Macrolide antibiotics and asthma treatment
Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy– treated mother  Sabine Flicker, PhD, Katharina Marth, MD, Heinz.
Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization.
Environmental factors and eosinophilic esophagitis
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Brian F. Leas, MS, MA, Kristen E. D'Anci, PhD, Andrea J
Presentation transcript:

Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood  Zaraquiza Zolkipli, MSc, Graham Roberts, DM, Victoria Cornelius, PhD, Bernie Clayton, RN, Sarah Pearson, RN, Louise Michaelis, MSc, Ratko Djukanovic, DM, Ramesh Kurukulaaratchy, DM, S. Hasan Arshad, DM  Journal of Allergy and Clinical Immunology  Volume 136, Issue 6, Pages 1541-1547.e11 (December 2015) DOI: 10.1016/j.jaci.2015.04.045 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Flow diagram of the study process. FU, Follow-up; ITT, intention to treat; OIT, oral immunotherapy. Journal of Allergy and Clinical Immunology 2015 136, 1541-1547.e11DOI: (10.1016/j.jaci.2015.04.045) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Cumulative sensitization to any common allergen (A) and HDM sensitization (B). OIT, Oral immunotherapy. Journal of Allergy and Clinical Immunology 2015 136, 1541-1547.e11DOI: (10.1016/j.jaci.2015.04.045) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Overview of study design. OIT, Oral immunotherapy. Journal of Allergy and Clinical Immunology 2015 136, 1541-1547.e11DOI: (10.1016/j.jaci.2015.04.045) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 Cumulative proportion with eczema for all participants (A) and excluding those with eczema at baseline (B). OIT, Oral immunotherapy. Journal of Allergy and Clinical Immunology 2015 136, 1541-1547.e11DOI: (10.1016/j.jaci.2015.04.045) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 Cumulative proportion with reported wheeze symptoms for all participants (A) and excluding those with wheeze at baseline (B). OIT, Oral immunotherapy. Journal of Allergy and Clinical Immunology 2015 136, 1541-1547.e11DOI: (10.1016/j.jaci.2015.04.045) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E4 Cumulative proportion with food allergy. OIT, Oral immunotherapy. Journal of Allergy and Clinical Immunology 2015 136, 1541-1547.e11DOI: (10.1016/j.jaci.2015.04.045) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions